MADISON HEIGHTS, MI / February 26, 2014 / ACCESSWIRE / Creative Edge Nutrition, Inc. (FITX), is proud to announce a partnership agreement with RXNB Inc. for the first right of purchase of a pharmacy license in the State of Michigan.

Under the agreement, CEN Biotech Inc. (A Michigan Corporation) is positioned to establish a gateway for distribution of naturally occurring pharmaceuticals in acknowledgement of Michigan Senate Bill 0660.

Senate Bill 0660 recognizes the sale of pharmaceutical-grade cannabis through licensed facilities; allowing under certain circumstances, the regulations of possession and use of pharmaceutical-grade cannabis by certain individuals. Effective December 30th 2013, the bill has published as a public law, passing both the Senate and the House successfully.

“Senate Bill 0660 is in line with our philosophy that medicinal marijuana is a controlled substance that must be recognized for its medicinal properties, which requires a licensed individual & entity to dispense to the patients accordingly, for various ailments” Bill Chaaban, CEO Creative Edge Nutrition states.

Mr. Chaaban continues discussing alternate avenues of dispensing, “We believe in responsible medicine and are not opposed to alternative and or new avenues of access to pharmaceutical-grade cannabis, but we still must recognize the implications of the failure to provide security, traceability and accountability”.

The agreement will allow for Creative Edge Nutrition to conduct business at the patient dispensing consumer level in the State of Michigan. Dr. Sam Alawieh, Pharm.D. explains “We are excited to continue our collaboration with CEN Biotech Inc. ( Canada), CEN Biotech Inc. (Michigan), & Creative Edge Nutrition Inc. to position ourselves in the market place to provide patients access to medicine responsibly, pending the position of the Federal government and pharmaceutical-cannabis’ schedule as a controlled substance.”

“To reiterate to date, we are looking forward to the co-operation of the many agencies required to make this a possibility to provide a fundamentally sound and responsible avenue for patients to have access to pharmaceutical-grade cannabis, in uniformity of all parties engaged, patients, physicians, municipalities, the State of Michigan and the Federal government”. Stated CEO & President of RXNB Inc. Dr. Sam Alawieh, Pharm.D.

RXNB Inc. currently practices patient-dispensing of medicine and has developed an infrastructure that allots Creative Edge Nutrition Inc. and its subsidiaries to solidify a presence in the pharmaceutical market place.

About CEN Biotech (Canada)

CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC Pink: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR) CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada.

About Creative Edge Nutrition, Inc.

Creative Edge Nutrition is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. http://www.cenergynutrition.com/ and https://www.facebook.com/CenergyNutrition

Safe Harbor Notice This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Story continues